Erlotinib Tablets

Erlotinib is a EGFR tyrosine kinase inhibitor supplied as tablets. It is used in standard clinical practice for non-small cell lung cancer and pancreatic cancer, as described in general pharmacological references.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.